Abstract 6-O-(3-Amino-3-deoxy-α-d-glucopyranosyl)-2-deoxystreptamine, which was previously synthesized, was masked with carbobenzoxy, isopropylidene and benzyl groups to give 6-O-(2-O-benzyl-3-carbobenzoxyamino-3-deoxy-4,6-O-isopropylidene-α-d-glucopyranosyl)-N,N′-dicarbobenzoxy-2-deoxystreptamine, with which 2,3,4-tri-O-benzyl-6-(N-benzylacetamido)-6-deoxy-α-d-glucopyranosyl chloride was condensed by a modified Koenigs-Knorr reaction, to give an α,α-diglycoside compound. The identity of the product with a substance of the same structure derived from natural kanamycin A was shown. Removal of the masking groups gave the synthetic kanamycin A, which was identical to the natural specimen.
No takes yet. Share an insight, caveat, or question.
Umezawa et al. (1969) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: